carnosine has been researched along with Diabetic Angiopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasetti Fantauzzi, C; Iacobini, C; Menini, S; Pugliese, G; Ricci, C | 1 |
| Belcaro, G; Cesarone, MR; Ciammaichella, G; Dugall, M; Hosoi, M; Ippolito, E; Luzzi, R | 1 |
| Davies, MJ; Rashid, I; van Reyk, DM | 1 |
3 other study(ies) available for carnosine and Diabetic Angiopathies
| Article | Year |
|---|---|
Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Carnosine; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Female; Glycation End Products, Advanced; Kidney; Mice; Mice, Knockout; Plaque, Atherosclerotic; Signal Transduction; Time Factors | 2015 |
Product evaluation of Ureadin Rx Db (ISDIN) for prevention and treatment of mild-to-moderate xerosis of the foot in diabetic patients. Prevention of skin lesions due to microangiopathy.
Topics: Administration, Cutaneous; Arginine; Carnosine; Dermatologic Agents; Diabetic Angiopathies; Diabetic Foot; Drug Combinations; Eczema; Female; Humans; Laser-Doppler Flowmetry; Lipids; Male; Microcirculation; Middle Aged; Pilot Projects; Pressure; Product Surveillance, Postmarketing; Skin; Surveys and Questionnaires; Ultrasonography; Urea | 2012 |
Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro.
Topics: beta-Alanine; Cardiovascular Diseases; Carnosine; Diabetic Angiopathies; Foam Cells; Glycosylation; Histidine; Humans; In Vitro Techniques; Lipoproteins, LDL; Macrophages | 2007 |